Angiolutions Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$2.76M
- Investors
-
9
Angiolutions General Information
Description
Developer of therapeutic devices designed for the treatment of vascular diseases. The company specializes in developing a novel vascular graft that prevents small abdominal aortic aneurysm growth, enabling healthcare professionals to assist patients in preventing and curing vascular diseases.
Contact Information
Website
www.angiolutions.comCorporate Office
- Vahrenwalder Straße 269A
- 30179 Hannover
- Germany
Corporate Office
- Vahrenwalder Straße 269A
- 30179 Hannover
- Germany
Angiolutions Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Grant | 27-Jul-2023 | $2.76M | Completed | Generating Revenue | ||
| 4. Seed Round | 01-Feb-2021 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Aug-2018 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Jan-2017 | Completed | Startup | |||
| 1. Accelerator/Incubator | Completed | Startup |
Angiolutions Patents
Angiolutions Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| DE-102023131688-A1 | Stent for the treatment of an abdominal aortic aneurysm | Pending | 14-Nov-2023 | ||
| AU-2024380229-A1 | Stent for treating an abdominal aortic aneurysm | Pending | 14-Nov-2023 | ||
| EP-4808484-A1 | Stent for treating an abdominal aortic aneurysm | Pending | 14-Nov-2023 | ||
| WO-2025104011-A1 | Stent for treating an abdominal aortic aneurysm | Inactive | 14-Nov-2023 | ||
| AU-2023382512-A1 | Self-expandable stent | Pending | 15-Nov-2022 | A61F2/915 |
Angiolutions Signals
Angiolutions Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| European Innovation Council | Accelerator/Incubator | Minority | ||
| Beteiligungsgesellschaft Stadt Solingen | Corporation | Minority | ||
| FRIBA Investment | Family Office | Minority | ||
| High-Tech Gründerfonds | Venture Capital | Minority | ||
| NBank Capital | Venture Capital | Minority |
Angiolutions FAQs
-
When was Angiolutions founded?
Angiolutions was founded in 2017.
-
Where is Angiolutions headquartered?
Angiolutions is headquartered in Hannover, Germany.
-
What is the size of Angiolutions?
Angiolutions has 9 total employees.
-
What industry is Angiolutions in?
Angiolutions’s primary industry is Therapeutic Devices.
-
Is Angiolutions a private or public company?
Angiolutions is a Private company.
-
What is Angiolutions’s current revenue?
The current revenue for Angiolutions is .
-
How much funding has Angiolutions raised over time?
Angiolutions has raised $2.25M.
-
Who are Angiolutions’s investors?
European Innovation Council, Beteiligungsgesellschaft Stadt Solingen, FRIBA Investment, High-Tech Gründerfonds, and NBank Capital are 5 of 9 investors who have invested in Angiolutions.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process